On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program called ReMIND at the September Independent Citizens’ Oversight Committee (ICOC) meeting that will eventually award up to $110 million to advance basic research in neuropsychiatric diseasesﾗone of the largest investments of its kind in California.

ReMIND was primarily developed in view of Proposition 14, which dedicates at least $1.5 billion of CIRM’s $5.5 billion total bond funding to the support of research and development of treatments for diseases and conditions of the brain and central nervous system.